Liver transplantation for HCV cirrhosis; cautious optimism after 10 years of experience

Annals of Transplantation

Volumn 17, Issue 4, 2012, Pages 5-10

  Pacholczyk, Marek ^a   Łagiewska, Beata ^a   Lisik, Wojciech ^a   Tronina, Olga ^a   Wasiak, Dariusz ^a   Cieciura, Tomasz ^a   Chmura, Andrzej ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antiviral therapy; HCV; Hepatitis recurrence; Liver transplantation

Indexed keywords

ALPHA2A INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ADULT; ARTICLE; FEMALE; FOLLOW UP; GENOTYPE; GRAFT SURVIVAL; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY FAILURE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPTIMISM; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SURVIVAL RATE; VIRUS LOAD; VIRUS REPLICATION;

ADULT; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REOPERATION; RIBAVIRIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875320173     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.883688     Document Type: Article

References (21)

1. http://www.onos.org/
2. Verna EC, De Martin E, Burra P et al: The impact of hepatitis c and biliary complications on patient and graft survival following liver transplantation. Am J Transplant, 2009; 9: 1398-405
3. Verna EC, Brown RS Jr: Hepatitis c virus and liver transplantation. Clin Liver Dis, 2006; 10: 919-40
4. Gane EJ, Portmann BC, Naoumov NV et al: Long-term outcome of hepatitis c infection after liver transplantation. N Engl J Med, 1996; 334: 815-20
5. Boker KH, Dalley G, Bahr MJ et al: Long-term outcome of hepatitis c virus infection after liver transplantation. Hepatology, 1997; 25: 203-10
6. Ziarkiewicz-Wroblewska B, Wroblewski T, Wasiutynski A: Morphological features and differential diagnosis of hepatitis c recurrence after liver transplantation-literature review and results of single transplantation center. Ann Transplant, 2008; 13: 12-20
7. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, Burgart L, Wiesner R, Kremers W, Rosen C, Charlton MR. Early identification of recipients with progressive histologic recurrence of hepatitis c after liver transplantation. Hepatology, 2000; 32: 1125-30
8. Chopra KB, Demetris AJ, Blakolmer K et al: Progression of liver fibrosis in patients with chronic hepatitis c after orthotopic liver transplantation. Transplantation, 2003; 76: 1487-91
9. Belli LS, Burroughs AK, Burra P et al: Liver transplantation for hcv cirrhosis: Improved survival in recent years and increased severity of recurrent disease in female recipients: Results of a long term retrospective study. Liver Transpl, 2007; 13: 733-40
10. Samonakis DN, Germani G, Burroughs AK: Immunosuppression and hcv recurrence after liver transplantation. J Hepatol, 2012; 56: 973-83
11. Cholongitas E, Tsochatzis E, Goulis J, Burroughs AK: Noninvasive tests for evaluation of fibrosis in hcv recurrence after liver transplantation: A systematic review. Transpl Int, 2010; 23: 861-70
12. De Martin E, Senzolo M, Boninsegna S et al: Hcv histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma. Transplant Proc, 2008; 40: 1974-75
13. Gallegos-Orozco JF, Yosephy A, Noble B et al: Natural history of post-liver transplantation hepatitis c: A review of factors that may influence its course. Liver Transpl, 2009; 15: 1872-81
14. Shackel NA, Jamias J, Rahman W et al: Early high peak hepatitis c viral load levels independently predict hepatitis c-related liver failure post-liver transplantation. Liver Transpl, 2009; 15: 709-18
15. Lai JC, Verna EC, Brown RS Jr et al: Hepatitis c virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology, 2011; 54: 418-24
16. Lake JR, Shorr JS, Steffen BJ et al: Differential effects of donor age in liver transplant recipients infected with hepatitis b, hepatitis c and without viral hepatitis. Am J Transplant, 2005; 5: 549-57
17. Berenguer M, Prieto M, San Juan F et al: Contribution of donor age to the recent decrease in patient survival among hcv-infected liver transplant recipients. Hepatology, 2002; 36: 202-10
18. Charlton M: Hepatitis c infection in liver transplantation. Am J Transplant, 2001; 1: 197-203
19. Nelson DR, Soldevila-Pico C, Reed A et al: Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis c recurrence after liver transplantation. Liver Transpl, 2001; 7: 1064-70
20. Vivarelli M, Burra P, La Barba G et al: Influence of steroids on hcv recurrence after liver transplantation: A prospective study. J Hepatol, 2007; 47: 793-98
21. http://www.eltr.org